BRPI0509861A - uso de simeticona em pacientes constipados - Google Patents

uso de simeticona em pacientes constipados

Info

Publication number
BRPI0509861A
BRPI0509861A BRPI0509861-0A BRPI0509861A BRPI0509861A BR PI0509861 A BRPI0509861 A BR PI0509861A BR PI0509861 A BRPI0509861 A BR PI0509861A BR PI0509861 A BRPI0509861 A BR PI0509861A
Authority
BR
Brazil
Prior art keywords
simethicone
patients
constipated patients
constipated
constipted
Prior art date
Application number
BRPI0509861-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Martina Gripp
Christoffel Schuijt
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BRPI0509861A publication Critical patent/BRPI0509861A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0509861-0A 2004-04-13 2005-04-12 uso de simeticona em pacientes constipados BRPI0509861A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04008736 2004-04-13
PCT/EP2005/003795 WO2005099821A1 (en) 2004-04-13 2005-04-12 Use of simethicone in constipated patients

Publications (1)

Publication Number Publication Date
BRPI0509861A true BRPI0509861A (pt) 2007-10-16

Family

ID=34924581

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509861-0A BRPI0509861A (pt) 2004-04-13 2005-04-12 uso de simeticona em pacientes constipados

Country Status (8)

Country Link
US (2) US20070281905A1 (enExample)
EP (1) EP1737537A1 (enExample)
JP (2) JP2008503445A (enExample)
BR (1) BRPI0509861A (enExample)
CA (1) CA2559239C (enExample)
RU (1) RU2384339C2 (enExample)
UA (1) UA86802C2 (enExample)
WO (1) WO2005099821A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007015982A (ja) * 2005-07-07 2007-01-25 Tendou Seiyaku Kk 緩下剤
DE102006001199A1 (de) * 2006-01-10 2007-07-12 Medicoforum Gmbh Fixe Kombination von Substanzen unter Beigabe von Entschäumern zum Einsatz als Darmspüllösung und/oder Laxans
WO2009036906A1 (de) * 2007-09-22 2009-03-26 Bayer Consumer Care Ag Zusammensetzung mit wirkstoffkombination aus einem laxans und einem entschäumer zur behandlung von obstipation
IT1405757B1 (it) * 2010-11-03 2014-01-24 Gruppo Farmaimpresa Srl Preparazione farmaceutica comprendente saccaromyces e simeticone per il trattamento delle patologie gastrointestinali
CN103338768B (zh) * 2010-12-13 2019-04-19 萨利克斯药品有限公司 胃和结肠的配制剂及其制备和使用方法
WO2014016671A2 (en) 2012-07-27 2014-01-30 Redhill Biopharma Ltd. Formulations and methods of manufacturing formulations for use in colonic evacuation
DE102012024434A1 (de) 2012-12-14 2014-06-18 Regalismons S.A. Verstärkung der entschäumenden Wirkung von Polysiloxanen, zugehöriger Zusammensetzungen und Lösungen
US20160151296A1 (en) * 2013-05-22 2016-06-02 Empire Technology Development Llc Long delayed release laxative
EP3402526B1 (en) * 2016-01-13 2021-03-24 Johnson & Johnson Consumer Inc. New improved composition comprising at least one cadotril
PT3586832T (pt) 2018-06-28 2021-04-06 Synformulas Gmbh Composição farmacêutica para o tratamento da obstipação

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150919A (ja) * 1984-08-20 1986-03-13 Tenkoushiya:Kk 人間及び動物用の便秘解消剤
DE4236025A1 (de) * 1992-10-24 1994-04-28 Merck Patent Gmbh Orale Arzneiformen
DE4341165C1 (de) * 1993-12-02 1995-04-20 Upmeyer Hans Juergen Verwendung von Dimeticon zur Behandlung von Obstipation
JPH07242557A (ja) * 1994-03-03 1995-09-19 Ss Pharmaceut Co Ltd 乳酸菌含有瀉下薬組成物
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
CN1288730A (zh) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
GB9925962D0 (en) * 1999-11-02 1999-12-29 Novartis Ag Organic compounds
JP2002003377A (ja) * 2000-06-20 2002-01-09 Taisho Pharmaceut Co Ltd ピコスルファートナトリウム配合緩下剤
JP2002003388A (ja) * 2000-06-20 2002-01-09 Nof Corp 便秘解消剤組成物
US6622856B2 (en) * 2001-04-25 2003-09-23 Johnson & Johnson Consumer Companies, Inc. Relief kit
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
WO2009036906A1 (de) * 2007-09-22 2009-03-26 Bayer Consumer Care Ag Zusammensetzung mit wirkstoffkombination aus einem laxans und einem entschäumer zur behandlung von obstipation

Also Published As

Publication number Publication date
US20120309715A1 (en) 2012-12-06
UA86802C2 (ru) 2009-05-25
US20070281905A1 (en) 2007-12-06
EP1737537A1 (en) 2007-01-03
JP2008503445A (ja) 2008-02-07
WO2005099821A1 (en) 2005-10-27
CA2559239C (en) 2021-04-06
JP2013010783A (ja) 2013-01-17
RU2006139819A (ru) 2008-05-20
CA2559239A1 (en) 2005-10-27
RU2384339C2 (ru) 2010-03-20

Similar Documents

Publication Publication Date Title
NL300889I2 (nl) Trifluridine in combinatie met tipiracilhydrochloride
UA93201C2 (ru) АНТИТЕЛО, KOTOPOE НЕЙТРАЛИЗУЕТ ЧЕЛОВЕЧЕСКИЙ TGF-b1
BR0309544A (pt) Preparação farmacêutica contendo oxicodona e naloxona
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
BR0213358A (pt) Uso de flibanserina
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
BRPI0618239A8 (pt) uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusicos
CA2683786C (en) Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects
PL1680128T3 (pl) Heksafosforan mio-inozytolu do stosowania miejscowego
BRPI0507966A (pt) uso de meloxicam para o tratamento de doenças respiratórias em porcos
BRPI0509861A (pt) uso de simeticona em pacientes constipados
WO2006050155A3 (en) Cancer therapeutic compositions
WO2008036448A3 (en) Composition and method of treating a sore throat
BRPI0513603A (pt) uso de hidroxicarbonato de lantánio e composição farmacêutica
NZ608266A (en) Administration of lorcaserin to individuals with renal impairment
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
BRPI0415232A (pt) uso de xenÈnio com hipotermia para tratar asfixia neonatal
BR0107960A (pt) Tratamento de condições alérgicas e inflamatórias
PT1220676E (pt) Prevencao do cancro colorrectal
TW200727905A (en) Treatment of chronic kidney disease (CKD) subjects using lanthanum compounds
BR0317947A (pt) Inibidores de quinurenina 3-hidroxilase para o tratamento de diabetes
EA200801890A1 (ru) Средство для лечения шума в ушах
DK1675611T3 (da) Terapeutiske anvendelser for C-peptid
GB0507598D0 (en) Composition
DE602005010203D1 (de) Pharmazeutische zusammensetzung enthaltend 2,4-dichlorbenzylalkohol und amylmetakresol

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/80 (2006.01), A61P 1/10 (2006.01), A61P 1/

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL